Concurrent HDAC and mTORC1 Inhibition Attenuate Androgen Receptor and Hypoxia Signaling Associated with Alterations in MicroRNA Expression

• Leigh Ellis,

  Affiliation Roswell Park Cancer Institute, Genitourinary Program, Grace Cancer Drug Center, Buffalo, New York, United States of America

  ⨯
• Kristin Lehet,

  Affiliation Roswell Park Cancer Institute, Genitourinary Program, Grace Cancer Drug Center, Buffalo, New York, United States of America

  ⨯
• Swathi Ramakrishnan,

  Affiliation Roswell Park Cancer Institute, Genitourinary Program, Grace Cancer Drug Center, Buffalo, New York, United States of America

  ⨯
• Remi Adelaiye,

  Affiliation Roswell Park Cancer Institute, Genitourinary Program, Grace Cancer Drug Center, Buffalo, New York, United States of America

  ⨯
• Kiersten M. Miles,

  Affiliation Roswell Park Cancer Institute, Genitourinary Program, Grace Cancer Drug Center, Buffalo, New York, United States of America

  ⨯
• Dan Wang,

  Affiliation Roswell Park Cancer Institute, Department of Bioinformatics, Buffalo, New York, United States of America

  ⨯
• Song Liu,

  Affiliation Roswell Park Cancer Institute, Department of Bioinformatics, Buffalo, New York, United States of America

  ⨯
• Peter Atadja,

  Affiliation Novartis Biomedical Research Institute, Shanghai, China

  ⨯
• Michael A. Carducci,

  Affiliation The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States of America

  ⨯
• Roberto Pili

  * E-mail: Roberto.pili@roswellpark.org

  Affiliation Roswell Park Cancer Institute, Genitourinary Program, Grace Cancer Drug Center, Buffalo, New York, United States of America

  ⨯